Champion transformative patient care by leading medical strategy for COPD biologics. Drive evidence generation and external engagement while collaborating with teams to align US medical efforts with global goals and clinical needs.

Shape the future of COPD treatment by leading US medical strategy, guiding cross-functional teams, and influencing clinical practice through innovative research and strategic evidence generation for patient-focused solutions.

Tackle advanced pharmaceutical sales by leveraging deep clinical expertise to engage healthcare professionals and drive strategic initiatives, enhancing patient care through innovative solutions in specialized therapeutic areas.

Engineer robust chromatography methods to optimize therapeutic proteins, ensuring quality from development to commercialization. Collaborate cross-functionally to drive analytical advancements and support regulatory submissions for impactful patient outcomes.